BACKGROUND: Non-adherence in hypertension is a global problem and promoting adherence is necessary to decrease cardiovascular mortality. AIMS: The purpose of this paper is to examine the measurement of adherence to medication taking in hypertensive patients. Adherence was evaluated primarily by means of MEMS (Medication Event Monitoring System, Aprex Corporation, Fremont, California) an electronic system that records the date and time of opening of the study medication container. Additional measurements such as change in urinary potassium level, capsule count, client self report and physician estimate of adherence were recorded. METHODS: A randomised clinical trial was used to assign patients to receive the study medication (potassium) or placebo. Descriptive statistics were used to answer the research questions. Frequency and percentage of responses to different measures of adherence were carried out as well as correlation between the measures. RESULTS: One hundred and seven subjects between the ages of 26 and 80 participated in the clinical trial. The results showed that adherence measures varied with lowest adherence from two items of self-report related to forgetfulness (46 and 55%) and stringent electronic monitoring with the MEMS (58%) to percentages in the 80–90 range for other self-report items and the general adherence scale. Electronic monitoring correlated best with capsule count at visit 5. Implications for health care providers are discussed.
Hill M.,Berk R.A..Psychological barriers to hypertension therapy adherence: instrument development and preliminary psychometric evidence.Cardiovasc Nurs. 1995;31 (6): 37-43
2.
Burke L.E.,Dunbar-Jacob J..Adherence to medication, diet, and activity recommendations: from assessment to maintenance.J Cardiovasc Nurs. 1995;9 (2): 62-79
3.
Fogarty J.S..Reactance theory and patient non-compliance.Soc Sci Med. 1997;45 (8): 1277-1288
4.
[4]Hamilton GA. State of the Science Paper, commissioned by the Case Management Society of America, Council for Case Management Accountability. Patient adherence, outcome indicators and measurement in Case Management Health Care, 1999
5.
Hays R.D.,DiMatteo M.R..Key issues and suggestions for patient compliance assessment: sources of information, focus of measures, and nature of response options.J Compl Health Care. 1987;2 (1): 37-53
6.
Kruse W.,Weber E..Dynamics of drug regimen compliance–its assessment by microprocessor-based monitoring.Eur J Clin Pharmacol. 1990;38:561-565
7.
[7]Rand C. Issues in the measurement of adherence. In: Schumaker, Schron, Ockene, editors. The handbook of health behavior change. New York: Springer Publishing Co, 1990. p. 102–10
8.
Ryan P.,Lauver D.R..The efficacy of tailored interventions.IMAGE, J Nurs Scholarship. 2002;34 (4): 331-337
9.
Haynes R.B.,McKibbon K.A.,Kanani R..Systematic review of randomised trial of interventions to assist patients to follow prescriptions for medication.The Lancet. 1996;348:383-386
10.
Hill M.N.Hypertension primer. 2nd edIzzo J.L.Black S.r., ed. Dallas, Texas: American Heart Association; 1999:348-351.
11.
Preventing stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP).J Am Med Assoc. 1991;265:3255-3264
12.
Grimm H.,Grandits G.A.,Cutlet J.A.,Stewart A.L.,McDonald R.H.,Svendsen K., et al.Liebson PR for the THOMHS research group. Relationships of quality of life measures to long-term lifestyle and drug treatment in the treatment of mild hypertension study (THOMHS).Arch Intern Med. 1997;157:638-648
13.
Hill M.N.,Becker D.M..Roles of nurses and health workers in cardiovascular health promotion.Am J Med Sci. 1995;310 (Suppl 1): S123-126
14.
Hill M.N.,Bone L.R.,Hilton S.C.,Roary M.C.,Kelen G.D.,Levine D.M..A clinical trial to improve high blood pressure care in young urban black men: recruitment, follow-up and outcomes.Am J Hypertension. 1999;12 (6): 548-554
15.
[15]Working Group on Health Education and High Blood Pressure Control, National High Blood Pressure Education Program. The physician's guide: Improving adherence among hypertensive patients. Bethesda, MD. US Department of Health and Human Services, NHLBI, 1987
16.
Binstock M.L.,Franklin K.L..A comparison of compliance techniques on the control of high blood pressure.Am J Hypertension. 1988;1 (3 part 3): 192S-194SA
17.
Uemura K.,Pisa Z..Trends in cardiovascular disease mortality in industrial countries since 1950.World Health Stat Q. 1988;41:155-168.29
18.
Deckers J.W..Towards prevention, and not just postponement of, atherosclerotic disease.Eur Heart J. 2002;23 (10): 771-772
19.
Marquas-Vidal P.,Tuomilehto J..Hypertension awareness, treatment and control in the community: is the ‘rate of halves’ still valid?.J Human Hypertension. 1997;11:213-220
[21]Murray CJL, Lopez (Eds.). The global burden of disease. a comprehensive assessment of morbidity and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. World Health Organization. Boston: Harvard University Press; 1996
22.
Colhoun H.M.,Dong W.,Poulter N.R..Blood pressure screening, management and control in England: results from the health survey for England 1994.J Hypertension. 1998;16:747-752
Cooper R.S.Hypertension primer. 2nd edIzzo J.L.Black S.r., ed. Dallas, Texas: American Heart Association; 1999:224-225.
25.
Burt V.L.,Cutler J.A.,Higgins M.,Horan M.J.,Labarthe D.,Whelton P., et al.Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991.Hypertension. 1995;26:60-69
26.
[26]Yenney SL, Behrens RA. Health promotion and business coalitions. US Chamber of Commerce, 1984
27.
Stewart A.L.,Greenfield S.,Hays R.D.,Wells K.,Rogers W.H.,Berry S.D..Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study.J Am Med Assoc. 1989;262:907-913
28.
[28]Krall RL. Interaction of compliance and patient safety. In: Cramer, Spilker, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991. p. 19–26
29.
[29]British Medical Journal. Principles of the Declaration of Helsinki. 1964;ii:177
30.
[30]Becker MH. Theoretical models of adherence and strategies for improving adherence. In: Schumaker, Schron, Ockene, editors. The handbook of health behavior change. New York: Springer Publishing Co, 1990. p. 5–43
31.
Cameron C..Patient compliance: recognition of factors involved and suggestions for promoting compliance with therapeutic regimens.J Adv Nur. 1996;24:244-250
32.
[32]Cramer JA. Overview of methods to measure and enhance patient compliance. In: Cramer, Spilker, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991. p. 3–10
33.
Given C.W.,Given B.A.,Coyle B.W..Prediction of patient attrition from experimental behavioral interventions.Nur Res. 1985;34:293-298
34.
Levine D.M.,Bone L..The impact of a planned health education approach on the control of hypertension in a high risk population.J Human Hypertension. 1990;4:317-321
35.
[35]Prochaska JO, Redding CA, Evers KE. The transtheoretical model and stages of change. In: Glanz, Lewis, Rimer, editors. 2nd ed. Health behavior and health education: theory, research and practice. San Francisco: Jossey-Bass, 1997. p. 60–84
36.
Becker M.H.The Health belief model and personal health behavior. NJ: Thorofare; 1974:
37.
Becker M.H.,Maiman L.A..Sociobehavioral determinants of compliance with health and medical care recommendations.Med Care. 1975;13:10-24
38.
Rosenstock I.M..Enhancing patient compliance with health recommendations.Pediatr Health Care. 1998;2 (2): 67-72
39.
Ajzen L.,Fishbein M.Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice-Hall; 1980:
40.
[40]Hamilton GA. A multivariate approach to compliance in hypertension. Unpublished Dissertation, Boston University, 1982
41.
Hamilton G.A.,Roberts S.J.,Johnson J.M.,Tropp J.R.,Anthony-Odgren D.,Johnson B..Increasing adherence in patients with primary hypertension: an intervention.Health Values. 1993;17 (1): 3-11
42.
Sherbourne C.D.,Hays R.D.,Ordway L.,DiMatteo M.R.,Kravitz R.L..Antecedents of adherence to medical recommendations: results from the medical outcomes study.J Behav Med. 1992;15 (5): 447-468
43.
DiMatteo M.R.,Sherbourne C.D.,Hays R.D.,Ordway L.,Kravitz R.L.,McGlynn E.A., et al.Physicians’ charcteristics influence patients’ adherence to medical treatment: results from the medical outcome study.Health Psychol. 1993;12 (2): 93-102
44.
[44]ACT Co-operative Agreement—Adherence in Clinucal Trials: Results of the ACT Cooperative Agreement Society for Clinical Trials, 19th Annual Meeting, Atlanta, GA, May 17–20, 1998
45.
Morisky D.E.,Green L.W.,Levine D.M..Concurrent and predictive validity of a self-report measure of medication adherence.Med Care. 1986;24 (1): 67-74
46.
Shea S.,Misra D.,Ehrlich M.H.,Field L.,Francis C.K..Correlates of nonadherence to hypertension measurement in an inner-city population.Am J Public Health. 1992;82 (12): 1607-1612
47.
Haynes R.B.,Sackett D.L.,Gibson E.S.,Taylor D.W.,Hackett B.C.,Roberts R.S., et al.Improvement of medication compliance in uncontrolled hypertension.Lancet. 1976;1:1265-1268
48.
Matsayuma J.R.,Mason B.J.,Jue S.G..Pharmacists’ interventions using an electronic medication-event device's adherence data versus pill counts.Ann Paharmacotherapy. 1993;27:851-855
49.
Straka R.J.,Fish J.T.,Benson S.R.,Suh J.T..Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug.Pharmacotherapy. 1997;17 (1): 126-132
50.
Caron H.S..Compliance: the case for objective measurement.J Hypertension. 1985;3 (Suppl. 1): 11-17
51.
DeGeest S.,Borgermans L.,Gemoets H.,Abraham I.,Vlaminick H.,Evers G., et al.Incidence, determinants and consequences of sub-clinical non-compliance with immunosuppressive therapy in renal transplant.Transplantation. 1995;59:340-347
52.
[52]Spilker B. Methods of assessing and improving patienr compliance in clinical trials. In: Cramer JA, Spilker, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991. p. 47–56
53.
Rudd P.,Ahmed A.,Zachary V.,Barton C.,Bonduelle D..Improved compliance measures: applications in an ambulatory hypertensive drug trial.Clin Pharmacol Therapeutics. 1992;48 (6): 676-685
54.
Guerrero D.,Rudd P.,Bryant-Kosling C.,Middleton B.F..Antihypertensive medication taking: investigation of a simple regimen.Am J Hypertension. 1993;6:586-592
55.
Vander Stichle R..Measure of patient compliance and the interpretation of randomized clinical trials.Eur J Clin Pharm. 1991;41:27-35
56.
Rand C.S.,Wise R.A..Measuring adherence to asthma medication regimens.Am J Respir Crit Care Med. 1994;149:S69-76
57.
Steele D.J.,Jackson T.C.,Gutmann M.C..Have you been taking your pills? The adherence-monitoring sequence in the medical interview.J Fam Pract. 1990;30:294-299
58.
Dunbar-Jacob J.,Dwyer K.,Dunning J..Compliance with anti-hypertensive regimen: a review of the research in the 1980s.Ann Behav Med. 1991;13 (1): 31-39
59.
Roter D.L.,Hall J.A.,Merisca R.,Nordstrom B.,Cretin D.,Svarstad B..Effectiveness of interventions to improve patient compliance: a meta-analysis.Med Care. 1998;36 (8): 1138-1161
